392 related articles for article (PubMed ID: 3302722)
1. A c-myc antisense oligodeoxynucleotide inhibits entry into S phase but not progress from G0 to G1.
Heikkila R; Schwab G; Wickstrom E; Loke SL; Pluznik DH; Watt R; Neckers LM
Nature; 1987 Jul 30-Aug 5; 328(6129):445-9. PubMed ID: 3302722
[TBL] [Abstract][Full Text] [Related]
2. Specific inhibition of c-myc protein biosynthesis using an antisense synthetic deoxy-oligonucleotide in human T lymphocytes.
Harel-Bellan A; Ferris DK; Vinocour M; Holt JT; Farrar WL
J Immunol; 1988 Apr; 140(7):2431-5. PubMed ID: 2450923
[TBL] [Abstract][Full Text] [Related]
3. Requirements for the simultaneous presence of phorbol esters and calcium ionophores in the expression of human T lymphocyte proliferation-related genes.
Kumagai N; Benedict SH; Mills GB; Gelfand EW
J Immunol; 1987 Sep; 139(5):1393-9. PubMed ID: 3114365
[TBL] [Abstract][Full Text] [Related]
4. Independent regulation of c-myc, B-myb, and c-myb gene expression by inducers and inhibitors of proliferation in human B lymphocytes.
Golay J; Cusmano G; Introna M
J Immunol; 1992 Jul; 149(1):300-8. PubMed ID: 1376749
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of nuclear proto-oncogenes in T cells triggered with mitogenic and nonmitogenic T3 and T11 activation signals.
Shipp MA; Reinherz EL
J Immunol; 1987 Oct; 139(7):2143-8. PubMed ID: 2821108
[TBL] [Abstract][Full Text] [Related]
6. Two different molecular pathways account for low IL-2 receptor and c-myc mRNA expression by lpr Lyt-2- L3T4- T cells.
Katagiri K; Katagiri T; Yokota S; Eisenberg RA; Cohen PL; Ting JP
J Immunol; 1988 Sep; 141(6):2145-52. PubMed ID: 3139753
[TBL] [Abstract][Full Text] [Related]
7. The role of the accessory cell in mitogen-stimulated human T cell gene expression.
Kern JA; Reed JC; Daniele RP; Nowell PC
J Immunol; 1986 Aug; 137(3):764-9. PubMed ID: 3088109
[TBL] [Abstract][Full Text] [Related]
8. Up-regulation of c-myc induces the gene expression of the murine homologues of p34cdc2 and cyclin-dependent kinase-2 in T lymphocytes.
Kim YH; Buchholz MA; Chrest FJ; Nordin AA
J Immunol; 1994 May; 152(9):4328-35. PubMed ID: 8157956
[TBL] [Abstract][Full Text] [Related]
9. Uncoupling of c-myc mRNA expression from G1 events in human T lymphocytes.
Friedrich B; Gullberg M; Lundgren E
Anticancer Res; 1988; 8(1):23-8. PubMed ID: 3128958
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-7 regulates c-myc expression in murine T cells and thymocytes: a role for tyrosine kinase(s) and calcium mobilization.
Seckinger P; Milili M; Schiff C; Fougereau M
Eur J Immunol; 1994 Mar; 24(3):716-22. PubMed ID: 7510242
[TBL] [Abstract][Full Text] [Related]
11. Proliferating cell nuclear antigen (PCNA)/cyclin in activated human T lymphocytes.
Kurki P; Lotz M; Ogata K; Tan EM
J Immunol; 1987 Jun; 138(12):4114-20. PubMed ID: 2884260
[TBL] [Abstract][Full Text] [Related]
12. The Chinese herbal remedy, T2, inhibits mitogen-induced cytokine gene transcription by T cells, but not initial signal transduction.
Tao X; Davis LS; Hashimoto K; Lipsky PE
J Pharmacol Exp Ther; 1996 Jan; 276(1):316-25. PubMed ID: 8558449
[TBL] [Abstract][Full Text] [Related]
13. Cellular oncogenes and lymphocyte activation.
Schneider-Schaulies J; Knauer R; Schimpl A; Wecker E
Behring Inst Mitt; 1987 Jun; (81):110-9. PubMed ID: 3115245
[TBL] [Abstract][Full Text] [Related]
14. Role of c-myc and other genes in interleukin 2 regulated CT6 T lymphocytes and their malignant variants.
Cleveland JL; Rapp UR; Farrar WL
J Immunol; 1987 May; 138(10):3495-504. PubMed ID: 3106484
[TBL] [Abstract][Full Text] [Related]
15. c-myc antisense oligodeoxyribonucleotides inhibit proliferation of non-small cell lung cancer.
Robinson LA; Smith LJ; Fontaine MP; Kay HD; Mountjoy CP; Pirruccello SJ
Ann Thorac Surg; 1995 Dec; 60(6):1583-91. PubMed ID: 8787447
[TBL] [Abstract][Full Text] [Related]
16. c-Myc protein is stabilized by fibroblast growth factor 2 and destabilized by ACTH to control cell cycle in mouse Y1 adrenocortical cells.
Lepique AP; Moraes MS; Rocha KM; Eichler CB; Hajj GN; Schwindt TT; Armelin HA
J Mol Endocrinol; 2004 Dec; 33(3):623-38. PubMed ID: 15591023
[TBL] [Abstract][Full Text] [Related]
17. Decreased steady state c-myc mRNA in activated T cell cultures from old humans is caused by a smaller proportion of T cells that transcribe the c-myc gene.
Gamble DA; Schwab R; Weksler ME; Szabo P
J Immunol; 1990 May; 144(9):3569-73. PubMed ID: 2184192
[TBL] [Abstract][Full Text] [Related]
18. Expression of the murine homologue of the cell cycle control protein p34cdc2 in T lymphocytes.
Kim YH; Proust JJ; Buchholz MJ; Chrest FJ; Nordin AA
J Immunol; 1992 Jul; 149(1):17-23. PubMed ID: 1637418
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of c-myc and the transferrin receptor in G1 synchronized M1 myeloid leukemia cells.
Neckers LM; Tsuda H; Weiss E; Pluznik DH
J Cell Physiol; 1988 May; 135(2):339-44. PubMed ID: 3372600
[TBL] [Abstract][Full Text] [Related]
20. Comparison of phorbol ester/calcium ionophore and phytohemagglutinin-induced signaling in human T lymphocytes. Demonstration of interleukin 2-independent transferrin receptor gene expression.
Kumagai N; Benedict SH; Mills GB; Gelfand EW
J Immunol; 1988 Jan; 140(1):37-43. PubMed ID: 3121740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
